Personal stories

It’s estimated that over 300 million people around the globe are living with a rare disease. For Rare Disease Day, here’s what to know.

The Johnson & Johnson Center for Health Worker Innovation is investing in open-source tech-based solutions that can be replicated in local contexts and are helping to extend the reach and capacity of the health workers to focus on where they can have the best and highest value.

Hetal Patel, an immunodermatology medical director at Johnson & Johnson, forged her own career path—and now she’s living into her passion for advocacy, education and innovation.

When Craig was diagnosed with multiple myeloma, his wife Cara took on a new role: caregiver. For National Caregiver’s Day, she shares the challenges—as well as the triumphs—of this difficult journey.

Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health. The winner for 2022 is internationally known for his research on the human gut microbiome and its impact on health and disease.

A commitment to social responsibility and innovation are just two of the attributes that helped the company land a spot on the prestigious list once again.

J&J Impact Ventures, an investment fund within J&J Foundation, is committed to transforming health systems by not just investing in a technology, service or delivery mechanism, but also the people committed to building trust for their market-driven solutions.

Based in Singapore, SwipeRx has grown into the largest digital pharmacy network across Southeast Asia, with a mobile app enabling pharmacies to operate more efficiently by acquiring supplies directly from the platform. J&J Impact Ventures, a fund within the Johnson & Johnson Foundation, supports SwipeRx in its work connecting over 245,000 pharmacy professionals who together build public health across the region.